Follow-up of sickle cell disease patients with priapism treated by hydroxyurea
✍ Scribed by Sara T.O. Saad; Camila Lajolo; Simone Gilli; José Francisco C. Marques Jr.; Carmen S. Lima; Fernando F. Costa; Valder R. Arruda
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 66 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Nothing to report. a Costs estimates for a 55-Kg patient based on: STT 5 2: filtered, washed, without buffy coat red blood cell units (250 ml Ht 80%)/ 4 week ? 249/ RBC U € 3 2 5 498 €. Desferoxamine f. 2g ? 11.05 € (40 mg/kg 3 5 days/week 5 11 g/week ? 5 f/ week 3 52 weeks/year). MEEX 5 2: fil
We report on the long-term clinical course of 4 boys with Menkes disease, treated from early infancy with parenteral copperhistidine, with follow-up over 10-20 years. Three of the 4 had male relatives with a severe clinical course compatible with classical Menkes disease. As a consequence of early t
Radial immunodiffusion (RID), alkaline cellulose acetate electrophoresis, and highperformance liquid chromatography (HPLC) were compared for quantitating the elevated (> 10%) level of fetal hemoglobin (HbF) found in the red blood cells of sickle cell disease patients undergoing treatment with hydrox